期刊文献+

大剂量维生素C预冲透析器对血液透析患者晚期氧化蛋白产物的影响 被引量:9

The effect of pre-rinsing with high-dose vitamin C for the dialyzer on advanced oxidation protein products in hemodialysis patients
暂未订购
导出
摘要 目的研究大剂量维生素C预冲透析器对血液透析患者晚期氧化蛋白产物(Advancedoxi-dationproteinproducts,AOPP)的影响。方法选择在重庆西南医院住院及门诊接受血液透析患者及同期门诊体检人群160名。分为正常对照组、尿毒症组、常规血液透析组和治疗组,分别检测循环AOPP的水平,差异进行显著性检验。结果尿毒症患者(未行血液透析)的AOPP水平较正常对照组显著升高,而经过半年血液透析的患者其AOPP水平较未透析患者又明显升高,但透析前经过大剂量维生素C预处理透析器后其AOPP明显下降(P均<0.01),差异有统计学意义。结论大剂量维生素C预冲透析器对血液透析患者AOPP升高有抑制作用。 Objective To investigate the effect of preconditioning high dose vitamin C for the dialyzer on advanced oxidation protein products(AOPP) in hemodialysis patients. Methods One hundred and sixty adults were randomly selected including in-patients in the nephrology ward and healthy subjects for routine medical examination. The subjects were classified into 4 groups: Normal subjects(NS),uremia (U), hemodialysis (HD) and therapy (T) group. The serum levels of AOPP were measured respectively. Results Serum levels of AOPP were significantly higher in uremia patients compared with healthy controls(P〈0. 01), while higher in HD patients than in uremia patients, but significantly lower in the therapy group than in HD group(P〈0. 01). Conclusion Preconditioning high dose vitamin C for the dialyzer can decrease AOPP in HD patients.
出处 《中国血液净化》 2006年第6期311-312,346,共3页 Chinese Journal of Blood Purification
关键词 维生素C 血液透析 AOPP 透析器 Vitamin C AOPP Hemodialysis Dialyzer
  • 相关文献

参考文献12

  • 1Descamps-Latscha B,Witko-Sarsat V.Importance of oxidatively modified proteins in chronic renal failure.Kidney Int,2001,78:S108
  • 2Drueke T,Witko-Sarsat V,Massy ZA,et al.Iron Therapy,advanced oxidation protein products.and carotid artery intima media thickness in end stage renal disease.Circulation,2002,106(17):2212
  • 3Witko-Sarsat V,Friedllander M,Nguyen KT,et al.Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure.J Immunol,1998,161(5):2524
  • 4Foley RN,Parfrey PS,Sarnak MJ.Clinical epidemiology of cardiovascular disease in chronic renal disease.Am J Kidney Dis,1998,32[SuPP13]:l12-119
  • 5Bostom AG,Lathrop L.HyPerhomocysteinemia in end-stage renal disease:Prevalence,etiology,and potential relationship to artherosclerotic outcomes.Kidney Int,1997,52:10-20
  • 6中华医学会肾脏病分会透析移植登记工作组,钱家麒,张伟明,徐筱琪.1999年度全国透析移植登记报告[J].中华肾脏病杂志,2001,17(2):77-78. 被引量:444
  • 7Ma KW,Greene EL,Reij L.Cardiovascular risk factors in chronic renal failure and hemodialysis populations.Am J Kid Dis,1992,19:505-513
  • 8Descamps-Latscha-B,Jungers-P,Witko-Sarsat-V.Immune system dysregulation in uremia:Role of oxidative stress.Blood-Purif,2002,20 (5):481-484
  • 9Descamps-Latscha,-B;Drueke,-T;Witko-Sarsat,-V.Dialysisinduced oxidative stress:biological aspects,clinical consequences,and therapy.Semin-Dial,2001,14(3):193-199
  • 10Witko-Sarsat,-V;Gausson,-V;Descamps-Latscha,-B.Are advanced oxidation protein products potential toxins? Kidney Int (Suppl),2003,(84):S11-14

共引文献443

同被引文献110

引证文献9

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部